USB
50
-3
MRO
50
4
SLB
52
-3
DOV
65
-4
EOG
56
-2
KIM
72
2
SWK
50
-5
LH
40
-5
GE
61
-3
ADP
65
-3
SYY
49
9
FAST
57
-3
SBUX
37
-2
XEL
67
2
URI
60
-6
GLW
45
-3
FIS
51
-4
PG
50
2
WU
24
4
PBI
56
-2
USB
50
-3
MRO
50
4
SLB
52
-3
DOV
65
-4
EOG
56
-2
KIM
72
2
SWK
50
-5
LH
40
-5
GE
61
-3
ADP
65
-3
SYY
49
9
FAST
57
-3
SBUX
37
-2
XEL
67
2
URI
60
-6
GLW
45
-3
FIS
51
-4
PG
50
2
WU
24
4
PBI
56
-2
Financhill
Back

Novartis AG Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
57

NVS
Novartis AG

Last Price:
103.07
Seasonality Move:
1.51%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
57
Novartis AG (NVS) is a Buy

Is Novartis AG a Buy, Sell or Hold?

  • The current Novartis AG [NVS] share price is $103.06. The Score for NVS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • NVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVS Stock Price Chart

What is Novartis AG's stock price today?

  • The Novartis AG share price today is $103.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

NVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.91 Sell
Relative Strength Index (14 RSI): 23.63 Sell
Chaikin Money Flow: 466049 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106.13 - 115.35) Sell
Bollinger Bands (100): (108.39 - 116.91) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

NVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.16 Sell
20-day SMA: 109.3 Sell
50-day SMA: 113.14 Sell
200-day SMA: 106.4 Sell
8-day EMA: 105.22 Sell
20-day EMA: 108.34 Sell
50-day EMA: 111.27 Sell
200-day EMA: 107.95 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Novartis AG Earnings Growth & NVS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Novartis AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):